Research

The objective of this multicentre cohort study, recently published in JAMA Internal Medicine, was to assess factors associated with death and to examine inter-hospital variation in treatment and outcomes for patients with COVID-19.

Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy

In this study recently published in the New England Journal of Medicine, the authors conducted a phase 1, dose-escalation, open-label trial including 45 healthy adults, 18 to 55 years of age, who received two vaccinations, 28 days apart, with candidate vaccine mRNA-1273 (which encodes the stabilised prefusion SARS-CoV-2 spike protein) in a dose of 25 μg, 100 μg, or 250 μg.

In this controlled, open-label trial recently published in the New England Journal of Medicine, the authors randomly assigned patients who were hospitalised with COVID-19 to receive either oral or intravenous dexamethasone (at a dose of 6 mg once daily) for up to 10 days or usual care.

Palliative care in neurology

DIRECT-MT: Should stroke patients selected for mechanical thrombectomy also receive intravenous thrombolysis?

Acute symptomatic seizures and SARS-CoV-2 encephalitis in COVID-19

EAN Scientific Panel Neuro-oncology invites you to take part in their survey

This EAN clinical practice guideline aims to provide practical help to clinicians caring for people with severe, progressive multiple sclerosis (MS).

In May 2020, the EAN published for the first time guidelines for the management of medication overuse headache (MOH).

COVID Breaking news: CNS injury biomarkers elevated in COVID patients

For July 2020, we have selected: Yang P. et al. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke

New randomised control trial evidence for treatment of status epilepticus

A new guideline on the palliative care for people with severe multiple sclerosis has been produced by EAN, in collaboration with ...

EAN aims to build a reading list of high-quality and up-to-date reviews on core neurology curriculum areas for registrars across Europe. The focus is clinical and practical, to guide neurology trainees learning their trade in optimal standards of diagnosis, investigation and management in daily clinical practice.